VICKERS VANTAGE CORP I (VCKA) Stock News

Sorrento Therapeutics (SRNE) Pops on FDA Fast Track Designation

Sorrento Therapeutics (SRNE) stock is getting a boost on Wednesday after the FDA granted it fast-track designation for SP-103.

Mentions: SRNE CHPT BBBY CHWY

VICKERS VANTAGE CORP. I EXTENDS TIME TO COMPLETE BUSINESS COMBINATION

NEW YORK, NY, April 11, 2022 (GLOBE NEWSWIRE) --   Vickers Vantage Corp. I (Nasdaq: VCKAU, VCKA, VCKAW) (“Vickers” or the “Company”), a Cayman Islands...

Sorrento's Pain Company Reveals Final Results For SP-102 Data For Sciatica Pain Management

Sorrento Therapeutics Inc's (NASDAQ: SRNE) subsidiary Scilex Holding Company has announced final results from its SP-102 Phase 3 Pivotal Trial C.L.E.A.R. Program.  SP-102 (Semdexa) has received Fast Track status from the FDA.

Mentions: SRNE

Vickers Venture SPAC To Merge With Sorrento Therapeutics' Pain-Focused Subsidiary

Vickers Venture Partners' special purpose acquisition company Vickers Vantage Corp I (NASDAQ: VCKA) will merge with Scilex Holding Company, focused on developing and commercializing non-opioid therapies for acute and chronic pain.

Mentions: SRNE

VICKERS VANTAGE CORP. I EXTENDS TIME TO COMPLETE BUSINESS COMBINATION

NEW YORK, NY, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Vickers Vantage Corp. I (Nasdaq: VCKAU, VCKA, VCKAW) (“Vickers” or the “Company”), a Cayman Islands...